Free Light Chains: Potential Biomarker and Predictor of Mortality in Alpha-1-Antitrypsin Deficiency and Usual COPD

Respiratory Research - United Kingdom
doi 10.1186/s12931-016-0348-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

S62 Polyclonal Free Light Chains: A Potential Biomarker for Immune Activation in Alpha-1-Antitrypsin Deficiency (A1ATD) Related Chronic Obstructive Pulmonary Disease: Abstract S62 Table 1.

Thorax
PulmonaryRespiratory Medicine
2013English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Differences in Adjustment Between Individuals With Alpha-1 Antitrypsin Deficiency (AATD)-Associated COPD and Non-Aatd COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease
MedicinePulmonaryRespiratory Medicine
2013English

Prevalence and Burden of Alpha-1 Antitrypsin Deficiency Among Hospitalized Copd Patients in the Us

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Alpha 1-Antitrypsin Deficiency and Liver Disease.

BMJ
1981English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha-1-Antitrypsin Deficiency: Increasing Awareness and Improving Diagnosis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy